Management of serious nosocomial bacterial infections: do current therapeutic options meet the need?
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (10) , 778-787
- https://doi.org/10.1111/j.1469-0691.2005.01220.x
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamasesDiagnostic Microbiology and Infectious Disease, 2001
- LinezolidDrugs, 2001
- In vitro evaluation of broad-spectrum β-lactams in the Philippines medical centers: role of fourth-generation cephalosporinsDiagnostic Microbiology and Infectious Disease, 1999
- In vitro evaluation of cefepime and other broad-spectrum β-lactams in Taiwan medical centersDiagnostic Microbiology and Infectious Disease, 1999
- Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest methodDiagnostic Microbiology and Infectious Disease, 1999
- Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance programDiagnostic Microbiology and Infectious Disease, 1999
- Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compoundsDiagnostic Microbiology and Infectious Disease, 1999
- Methicillin-ResistantStaphylococcus aureus in EuropeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991
- Kinetics of antimicrobial activityThe Journal of Pediatrics, 1986